Drug
Pcs-499 clinical trials
Also written PCS499 and CTP-499.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2011
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2011 (2)
| Year | Studies |
|---|---|
| 2011 | 2 |
| 2012 | 1 |
| 2018 | 2 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Processa Pharmaceuticals (3) · Concert Pharmaceuticals (3)
Studies
Open first, then newest update. How each study uses pcs-499 is read from its arms, and is right about nine times in ten.
Testing it · 6
- A Study to Evaluate the Safety and Tolerability of PCS499 for the Treatment of Necrobiosis LipoidicaCompletedPhase 2Processa PharmaceuticalsNCT03698864Written as PCS499
- A Clinical Trial to Evaluate PCS499 in Treating Ulcerations in Patients Who Have Necrobiosis LipoidicaTerminatedPhase 2Processa PharmaceuticalsNCT04800562Written as PCS499
- A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy PatientsCompletedPhase 2Concert PharmaceuticalsNCT01487109Written as CTP-499
- Study to Evaluate the PK of Single and Optional Multiple Dosing Regimens of MR Formulations of PCS499 Compared to Trental® Administered to Healthy SubjectsCompletedPhase 1Processa PharmaceuticalsNCT03836222Written as PCS499
- Safety & Tolerability Study of CTP-499 in Patients With Moderate Chronic Kidney DiseaseCompletedPhase 1Concert PharmaceuticalsNCT01460199Written as CTP-499
- Safety, Tolerability, and Pharmacokinetics (PK) of CTP-499CompletedPhase 1Concert PharmaceuticalsNCT01328821Written as CTP-499